Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations

Diagnostic Microbiology and Infectious Disease

Volumn 49, Issue 1, 2004, Pages 47-52

  Doktor, Stella Z ^a   Shortridge, Virginia D ^a   Beyer, Jill M ^a   Flamm, Robert K ^a,b  

^a ABBOTT LABORATORIES   (United States)

^b Focus Technologies Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; KETOLIDE; LINCOSAMIDE; MACROLIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIUM ISOLATE; BASE PAIRING; EPIDEMIOLOGICAL DATA; GENE DUPLICATION; GENE INSERTION; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; PNEUMOCOCCAL INFECTIONS; RNA, RIBOSOMAL, 23S; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 2342525087     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00130-5     Document Type: Article

References (12)

1. Canu A., Malbruny B., Coquemont M., Davies T., Appelbaum P., Leclercq R. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother. 46:2002;125-131
2. Colman G., Cooke E.M., Cookson B.D., Cooper P.G., Efstratiou A., George R.C. Pneumococci causing invasive disease in Britain 1982-1990. Med Microbiol. 47:1998;17-27
3. Depardieu F., Courvalin P. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob Agents Chemother. 45:2001;319-323
4. Havarstein L.S., Coomaraswamy G., Morrison D. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci USA. 92:1995;11140-11144
5. Musher D.M., Dowell M.E., Shortridge V.D., Flamm R.K., Jorgensen J.H., Le Magueres P., Krause K.L. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. NEJM. 346:2002;630-631
6. th ed., vol M7-A5. Approve standard. 2000;NCCLS, Wayne, Pa
7. Schlunzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrechts R., Yonath A., Franceschi F. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 413:2001;814-821
8. Shortridge V.D., Zhong P., Cao Z., Beyer J.M., Almer L.S., Ramer N.C., Doktor S.Z., Flamm R.K. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide -susceptible and -resistant Streptococci and Staphylococci. Antimicrob Agents Chemother. 46:2002;783-786
9. Tait-Kramradt A., Davies T., Cronan M., Jacobs M.R., Appelbaum P.C., Sutcliffe J. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother. 44:2002;2118-2125
10. Tait-Kamradt A., Davies T., Appelbaum P.C., Depardieu F., Courvalin P., Petitpas J., Wondrack L., Walker A., Jacobs M.R., Sutcliffe J. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother. 44:2000;3395-3401
11. Vester B., Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother. 45:2001;1-12
12. Yu L., Gunasekera A.H., Mack J., Olejniczak E.T., Chovan L.E., Ruan X., Towne D.L., Lerner C.L., Fesik S.W. Solution structure and function of a conserved protein SP14.3 encoded by an essential Streptococcus pneumoniae gene. JMB. 311:2001;593-604